AMPE — Ampio Pharmaceuticals Share News
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
Brief: Ampio Provides Update On Results From Pre-IND Enabling Studies
Brief: Ampio Selects Ascendia Pharmaceuticals, Inc. To Provide CDMO Services To Support Clinical Development Of OA-201
Brief: Ampio Pharmaceuticals Announces Reverse Stock Split
Brief: Ampio Pharmaceuticals Inc - Holds Approximately $1.25 Million In A Deposit Account At Silicon Valley Bank
Brief: Ampio Pharmaceuticals Regains Compliance With NYSE American Continued Listing Standards
Brief: Ampio Pharmaceuticals Issues Letter To Stockholders
AMEX HALT NEWS PENDING LAST 0.058400
Brief: Ampio Pharmaceuticals - Committed To Reduction In Force That Will Result In The Termination Of 10 Of The Co's 18 Employees
Brief: Ampio Pharmaceuticals Issues Letter To Stockholders
Brief: Ampio Pharmaceuticals' CEO Mike Martino Issues Letter To Stockholders
Ampio Pharma slides after launching internal probe
Brief: Ampio Says FDA Does Not Consider Data From AP-013 Sufficient To Demonstrate Efficacy As Second Pivotal Trial
Brief: Ampio Pharmaceuticals Reports First-Quarter Financial Results
Ampio Pharma slides as new study likely needed for pain drug
Brief: Ampio Provides Regulatory Update
Brief: Ampio Pharmaceuticals Reports Fourth-Quarter Financial Results
Ampio Pharma rises on positive data from joint disease study
Brief: Ampio Pharmaceuticals Releases Positive Phase 3 Data Analysis For Ampion Targeting Severe Osteoarthritis Of The Knee (Oak)
Brief: Ampio Expands Board Of Directors With Addition Of Elizabeth Varki Jobes